Likewise, the relevance to CHD risk of HDL-related apolipoproteins beyond ApoA1 (ApoA2, ApoA4, ApoD, ApoH, ApoL1, and ApoM) is not well understood. This evidence concerns the gene APOL1 and coronary artery disorder.